Background of De-Escalation Approach to HER2+ Breast Cancer Treatment
Neil Vasan, MD, PhD, discusses how past studies have supported de-escalated approaches and other improvements to treatment for patients with HER2-positive breast cancer.
TRAIN-2 Trial Leads to Changes in Treatment of HER2+ Breast Cancer
Neil Vasan, MD, PhD, discusses how the results of the TRAIN-2 trial impacted the treatment of patients with HER2-positive breast cancer.